DEA Approval Necessary to Act on Recent Amendments to Illinois Law Granting APNs and PAs the Authority to Prescribe Schedule II Controlled Substances
Healthcare Alert | 1 min read
Feb 5, 2010
In August 2009, three Illinois Acts were amended, granting Advanced Practice Nurses (APNs) and Physician Assistants (PAs) the authority to prescribe Schedule II controlled substances. The Illinois Nurse Practice Act, Physician Assistant Act and Controlled Substances Act that had previously authorized the delegation of prescriptive authority (pursuant to a written collaborative or supervision agreement) only in regard to Schedule III-V controlled substances, now permit the delegation of such authority for Schedule II substances. Despite the state law amendments, however, APNs and PAs practicing in Illinois must await formal DEA approval before registering for updated state and federal controlled substances registration.
Under the amended Acts, APNs and PAs will have limited prescriptive authority. Specifically, APNs and PAs may be delegated no more than five Schedule II controlled substances by oral dosage and all prescriptions must be limited to no more than a 30-day oral dosage. In addition, only those controlled substances that the collaborating or supervising physician prescribes may be delegated, and the APN or PA must meet with the collaborating or supervising physician monthly to discuss the condition of those patients for whom a controlled substance is prescribed.
DEA approval is expected later this year. Upon approval, the Illinois Department of Financial and Professional Regulation will release updated forms and applications for revised controlled substances registration. After acquiring proper state registration, APNs and PAs will be required to apply for a revised or updated DEA number. Both must be obtained prior to acting upon the delegation of authority permitted under the recent statutory amendments.
For more information, please contact Stephen T. Moore or your regular Hinshaw attorney.
This alert has been prepared by Hinshaw & Culbertson LLP to provide information on recent legal developments of interest to our readers. It is not intended to provide legal advice for a specific situation or to create an attorney-client relationship.
Related People
Related Capabilities
Featured Insights

Press Release
Sep 18, 2026
Paris Glazer Named to Chicago Daily Law Bulletin’s 2026 40 Attorneys Under Forty

Consumer Crossroads: Where Financial Services and Litigation Intersect
Sep 17, 2026
Federal and State Regulators Continue Crackdown on Junk Fees

Press Release
Sep 17, 2026
Defense Verdict Reduces $134 Million Demand to $2 Million in Catastrophic Motorcycle Injury Case

Insights for Insurers Alert
Sep 16, 2026
America 250: The Nation’s Unique Contributions to Insurance Coverage Law and Litigation

In The News
Sep 15, 2026
Lucy Wang Discusses the California Insurance Commissioner’s Role in Protecting Consumers

Press Release
Sep 10, 2026
Hinshaw Attorneys Recognized as 2027 Lexology Index Thought Leaders: USA

In The News
Sep 10, 2026
Nicholas Ajello and Gregory Emry Analyze FAA’s Proposed BVLOS Drone Regulations

Consumer Crossroads: Where Financial Services and Litigation Intersect
Sep 9, 2026
“Play Now, Arbitrate Later”—“Not So Fast,” Ninth Circuit Says

In The News
Sep 9, 2026
Jennifer Driscoll Discusses “Patchwork” of Laws Targeting Personalized Pricing

Employment Law Observer
Sep 8, 2026
Five Workplace Issues Every Employer Should Address Before They Become a Costly Lawsuit

Press Release
Sep 8, 2026
Jim Sandy Appointed Chair of ABA Debt Collection and Bankruptcy Subcommittee


